| Vial description: |
ADRA2R, ADRAR, Alpha-2A adrenoceptor, Alpha-2A adrenoreceptor, ADRA2A |
| Category: |
primary antibody |
| Raised in: |
Rabbit |
| Clone: |
1 vial |
| Form: |
Affinity Purified |
| Reactivity: |
Mouse, Rat, Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P08913 |
| Application: |
Immunocytochemistry/Immunofluorescence |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
2 or 3 and , Freeze thaw will destroy a percentage in every cycle and should be avoided, However, In this sense, The receptors are ligand binding factors of type 1, This antibody needs to be stored at + 4°, When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, chemokinesor cytokines e, e, sometimes in pharmacology, such as enzymes, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, transporters and ion-channels, - or alpha protein sometimes glycoprotein present in blood, C in a fridge short term in a concentrated dilution, The anti-Alpha-2A adrenergic receptor / ADRA2A Antibody is a &alpha, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
Alpha-2A adrenergic receptor / ADRA2A |
| Short name: |
anti-Alpha-2A adrenergic receptor / ADRA2A Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
antibody to-a-2A adrenergic receptor / adrenoceptor a 2A (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ADRA2 and ADRA2R and ADRAR and ALPHA2AAR and ZNF32, ADRA2A and IDBG-89698 and ENSG00000150594 and 150, Adra2a and IDBG-177063 and ENSMUSG00000033717 and 11551, Plasma membranes, norepinephrine binding, this GO :0001819 and positive regulation of cytokine production and biological process this GO :0002526 and acute inflammatory response and biological process this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0004935 and adrenergic receptor activity and molecular function this GO :0004938 and alpha2-adrenergic receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006112 and energy reserve metabolic process and biological process this GO :0006260 and DNA replication and biological process this GO :0006928 and cellular component movement and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007194 and negative regulation of adenylate cyclase activity and biological process this GO :0007265 and Ras protein signal transduction and biological process this GO :0007266 and Rho protein signal transduction and biological process this GO :0007565 and female pregnancy and biological process this GO :0007596 and blood coagulation and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0010700 and negative regulation of norepinephrine secretion and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0016323 and basolateral plasma membrane and cellular component this GO :0019229 and regulation of vasoconstriction and biological process this GO :0019901 and protein kinase binding and molecular function this GO :0030036 and actin cytoskeleton organization and biological process this GO :0030168 and platelet activation and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0030818 and negative regulation of cAMP biosynthetic process and biological process this GO :0031692 and alpha-1B adrenergic receptor binding and molecular function this GO :0031696 and alpha-2C adrenergic receptor binding and molecular function this GO :0031996 and thioesterase binding and molecular function this GO :0032147 and activation of protein kinase activity and biological process this GO :0032148 and activation of protein kinase B activity and biological process this GO :0032795 and heterotrimeric G-protein binding and molecular function this GO :0032811 and negative regulation of epinephrine secretion and biological process this GO :0032870 and cellular response to hormone stimulus and biological process this GO :0035625 and epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway and biological process this GO :0042593 and glucose homeostasis and biological process this GO :0042596 and fear response and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043235 and receptor complex and cellular component this GO :0043268 and positive regulation of potassium ion transport and biological process this GO :0043406 and positive regulation of MAP kinase activity and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045202 and synapse and cellular component this GO :0045741 and positive regulation of epidermal growth factor-activated receptor activity and biological process this GO :0045909 and positive regulation of vasodilation and biological process this GO :0045955 and negative regulation of calcium ion-dependent exocytosis and biological process this GO :0046676 and negative regulation of insulin secretion and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0050796 and regulation of insulin secretion and biological process this GO :0050892 and intestinal absorption and biological process this GO :0050955 and thermoception and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051044 and positive regulation of membrane protein ectodomain proteolysis and biological process this GO :0051379 and epinephrine binding and molecular function this GO :0051380 and norepinephrine binding and molecular function this GO :0051926 and negative regulation of calcium ion transport and biological process this GO :0061179 and negative regulation of insulin secretion involved in cellular response to glucose stimulus and biological process this GO :0070473 and negative regulation of uterine smooth muscle contraction and biological process this GO :0071878 and negative regulation of adrenergic receptor signaling pathway and biological process this GO :0071881 and adenylate cyclase-inhibiting adrenergic receptor signaling pathway and biological process this GO :0071882 and phospholipase C-activating adrenergic receptor signaling pathway and biological process this GO :0071883 and activation of MAPK activity by adrenergic receptor signaling pathway and biological process this GO :0090303 and positive regulation of wound healing and biological process this GO :1901020 and negative regulation of calcium ion transmembrane transporter activity and biological process, this GO :0004930 : G-protein coupled receptor activity, this GO :0004930 : G-protein coupled receptor activity and also this GO :0004935 : adrenergic receptor activity and also this GO :0004938 : alpha2-adrenergic receptor activity and also this GO :0005515 : protein binding and also this GO :0019901 : protein kinase binding and also this GO :0031692 : alpha-1B adrenergic receptor binding and also this GO :0031696 : alpha-2C adrenergic receptor binding and also this GO :0031996 : thioesterase binding and also this GO :0032795 : heterotrimeric G-protein binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046982 : protein heterodimerization activity and also this GO :0051379 : epinephrine binding and also this GO :0051380 : norepinephrine binding, this GO :0004935 : adrenergic receptor activity, this GO :0004938 : alpha2-adrenergic receptor activity, this GO :0005515 : protein binding, this GO :0019901 : protein kinase binding, this GO :0031692 : alpha-1B adrenergic receptor binding, this GO :0031696 : alpha-2C adrenergic receptor binding, this GO :0031996 : thioesterase binding, this GO :0032795 : heterotrimeric G-protein binding, this GO :0042803 : protein homodimerization activity, this GO :0046982 : protein heterodimerization activity, this GO :0051379 : epinephrine binding, this GO :0051380 : norepinephrine binding, adrenoceptor alpha 2A |
| Identity: |
281 |
| Gene: |
ADRA2A |
More about : ADRA2A |
| Long gene name: |
adrenoceptor alpha 2A |
| Synonyms gene: |
ADRA2 ADRA2R |
| Synonyms gene name: |
adrenergic, alpha-2A-, receptor |
| Synonyms: |
ADRAR |
| Synonyms name: |
alpha-2AAR subtype C10 alpha-2A-adrenergic receptor |
| Locus: |
10q25, 2 |
| Discovery year: |
1990-09-10 |
| GenBank acession: |
AF284095 |
| Entrez gene record: |
150 |
| RefSeq identity: |
NM_000681 |
| Classification: |
Adrenoceptors |
| Havana BLAST/BLAT: |
OTTHUMG00000019050 |